PubMed HealthSearch

PubMed · 7281408

Left atrial transport function.

Abstract

These studies show that the left atrial booster pump action serves as a supercharger which can increase left ventricular stroke volume in the range of 25 percent; and in patients with aortic stenosis, stroke work in the range of 50 percent (4). These changes can occur in the face of increased resistance to left ventricular filling in clinical conditions such as aortic stenosis where there is diminished left ventricular compliance and in mitral stenosis where there is stenotic resistance to left ventricular filling from the atrium. In spite of this fact, assessment of left atrial function by measurement of cardiac output changes occurring after return from atrial fibrillation to normal sinus rhythm yields erratic and confusing results. The reason for this is that atrial function, per se, is not a primary determinant of steady state cardiac output. Sequential A-V pacing may temporarily increase stroke volume in an acute setting like myocardial infarction. Nevertheless, one cannot infer from such observations that the use of permanent transvenous A-V sequential pacing will augment steady state cardiac output over a period of time. This is an important point to remember when considering the use of sequential A-V pacing, since it requires insertion of more complicated pacing and sensing wires as well as a more complex circuitry. All of these features lead to an increased risk of pacemaker malfunction. This increased risk of malfunction is not justified unless there is good evidence that atrial contribution is important in a given patient.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J J Leonard, J Shaver, M Thompson. 1981. Left atrial transport function.. https://pubmed.ncbi.nlm.nih.gov/7281408/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Transvalvular Flow Rate is Associated With Mortality Rate and Lifetime Loss in Aortic Valve Stenosis: A Meta-Analysis of Reconstructed Time-to-Event Data.

Low-flow states are associated with adverse outcomes in aortic stenosis (AS), but the prognostic value of transvalvular flow rate (TFR) has not been consistently established across studies. This study is a systematic review and meta-analysis of reconstructed time-to-event data was performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-analyses. PubMed/MEDLINE, EMBASE, and Cochrane Library were searched for studies (published by November 14, 2025) comparing low versus normal TFR in AS. Data were collected from Kaplan-Meier curves. The primary endpoint was all-cause mortality. Survival was assessed using pooled Kaplan-Meier curves, Cox regression, flexible parametric survival models, and restricted mean survival time (RMST) analysis. A total of 9 studies including 6,494 patients were analyzed; 2,575 (39.7%) had low TFR. At 8 years of follow-up, estimated survival was 34.1% (95% confidence interval [CI] 24.7% to 47%) in the low-TFR group and 63% (95% CI 58.9% to 67.4%) in the normal-TFR group. Low TFR was associated with higher all-cause mortality (hazard ratio 1.59, 95% CI 1.45 to 1.74, p < 0.001). We observed a progressively greater hazard over time, with the hazard ratio approaching 1.9 by 8 years. At 8 years, RMST in the normal-TFR group was 7.37 years (95% CI 7.21 to 7.53 years) versus 5.07 years (95% CI 4.91 to 5.23 years) in the low-TFR group, representing a lifetime loss of 2.3 years in the low-TFR group (&#x394;RMST -2.30 years, 95% CI -2.53 to -2.07 years, p < 0.001). In patients with AS, low TFR is associated with significantly higher mortality and lifetime loss. These findings support TFR as a clinically meaningful marker for risk stratification in AS.

Aortic Valve Stenosis